Bordawekar, Mangesh S.
Pudipeddi, Madhu
Ruegger, Colleen E.
Dhareshwar, Sundeep S. https://orcid.org/0000-0003-2328-1661
Article History
Received: 21 March 2023
Accepted: 30 May 2023
First Online: 7 July 2023
Declarations
:
: The authors are shareholders of Novartis Pharmaceuticals Corporation (MSB, CER, SSD). No grants were awarded from any funding agency in the public, commercial, or not-for-profit sectors. The authors declare no competing interests.